Grindr (NYSE:GRND) said it has agreed to acquire PurposeMed Inc., the parent company of Freddie, a Canadian telehealth provider of HIV pre-exposure prophylaxis, or PrEP, that is expanding in the United States.
Chief Executive Officer George Arison described the transaction as the company’s first major step toward building “Grindr Health,” a healthcare business centered initially on PrEP access, testing, care and medication delivery. Grindr said it sees an opportunity to use its app’s user base and Freddie’s clinical, pharmacy and telehealth infrastructure to expand PrEP adoption among gay men.
Transaction Terms and Financial Expectations
Grindr agreed to pay $250 million upfront for PurposeMed, consisting of $190 million in cash and $60 million in stock. The deal also includes up to $70 million in additional cash consideration tied to performance targets. Both companies’ boards have approved the transaction, which Grindr expects to close in the fourth quarter, subject to customary conditions.
Chief Financial Officer John North said Freddie serves approximately 25,000 active patients and expects to generate more than $80 million in revenue and more than $10 million in adjusted EBITDA in 2026. The acquisition is expected to be immaterial to Grindr’s 2026 results, North said.
The company plans to provide its first combined-company 2027 outlook during its November earnings call. North said Grindr anticipates “another year of robust growth” in 2027, including an accretive EBITDA contribution from Freddie even after growth investments and fixed infrastructure costs.
Freddie’s current margins reflect investment in infrastructure supporting its U.S. expansion, according to North. Grindr expects the acquired business to be modestly dilutive to EBITDA margin percentage initially, but said healthcare margins could improve toward levels comparable with its core business—above 40%—as patient volume grows.
PrEP Opportunity and Care Model
Arison said about 400,000 U.S. Grindr users report taking PrEP, compared with an estimated 650,000 to 700,000 active U.S. PrEP prescriptions overall. Grindr estimates that more than 2 million additional U.S. users should be on PrEP based on their health needs.
He said access to PrEP can be burdensome because patients typically need bloodwork and physician visits four times each year. Freddie’s telehealth model aims to simplify that process, including by enabling bloodwork to be completed privately at home, according to Arison.
North said Freddie works with federally qualified community health clinics in the U.S., allowing eligible providers to purchase medications at discounted prices and use reimbursement proceeds to support patient care. He said the program operates among patients, health clinics, pharmacies and drug companies and does not rely on government funding.
Freddie earns recurring fees from telehealth and pharmacy services as patients remain in care and refill prescriptions. North said its combined U.S. telehealth and pharmacy model generates more than $400 in monthly revenue per active patient, or more than $4,800 for a full year of care. Eligible patients may receive care with little or no out-of-pocket cost.
- At 50,000 patients, Grindr said the business could represent roughly $240 million in revenue.
- Freddie accounts for about 30% of PrEP prescriptions in Canada, according to Grindr.
- North said applying that share to the U.S. market would equate to approximately 200,000 patients.
Arison identified MISTR and Q Care Plus, a subsidiary of Avita, as the other significant U.S. telehealth providers in the PrEP market. He said an estimated 85% of current PrEP patients receive treatment through primary-care physicians rather than telehealth providers.
Integration Plans and Healthcare Expansion
Grindr plans to integrate Freddie’s services deeply into its app, linking care options to the company’s existing user experience. Arison said the company’s prior work with Woodwork, its healthcare partner, showed that users were willing to engage with healthcare offerings in the app and that more native, integrated experiences performed better than conventional advertising.
Grindr plans to combine Woodwork’s offerings with Freddie’s services over time. Arison said users could eventually access PrEP, erectile dysfunction medications, GLP-1 treatments, peptides and sexual health management through a single experience. He also cited hair-growth and skincare products as potential future offerings, while describing longevity-focused care as a longer-term opportunity.
North said margin expansion at Freddie is expected to come primarily from patient growth and operating leverage rather than cost synergies. Freddie’s per-patient revenue is relatively consistent regardless of scale, he said, while the required clinical, privacy, regulatory and pharmacy infrastructure can support a larger patient base.
Arison said Grindr’s objective is not only to capture a larger share of existing PrEP patients, but also to increase overall adoption. He said PrEP prescriptions are growing at roughly 10% annually and that doubling the number of users on PrEP over five years could mean 300,000 additional people receiving the medication and potentially prevent 5,000 HIV infections each year.
About Grindr (NYSE:GRND)
Grindr Inc operates a social networking and online dating platform designed primarily for the LGBTQ+ community. Its flagship Grindr app enables users to discover and connect with people nearby, create profiles, exchange messages, share photos, and use location-based features for social and dating purposes.
The company offers a free version of its service supported by advertising, along with paid subscription products that provide additional features, including expanded browsing and messaging capabilities.
